IGWG Briefing Paper on Patent Pools

Sunday, 03 June 2007


 

IGWG Briefing Paper on Patent Pools

Collective Management of Intellectual Property  — The use of Patent Pools to expand access to essential medical technologies

KEI Research Note 2007:3 (1)

Continue Reading

Notes on the Bayh-Dole Act of 1980

Sep 2, 2009 The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed… Continue Reading

Abbott sought compulsory license in 2007 US patent dispute

Sunday, 29 April 2007

(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
 

On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.

 

Continue Reading

Novartis (NVS): Some Examples of Joint Ventures, Partnerships, and Alliances

Wednesday, 29 August 2007

According to the Novartis strategic alliances webpage, the company is engaged in "More than 400 collaborations in over 20 countries, over 120 collaborations with major biotech companies, and over 280 collaborations with academic centers."

Selected Joint Ventures, Partnerships, and Alliances with Big Pharma 


Novartis and Bayer Schering AG  – PTK/ZK – These two companies initially collaborated in the devel Continue Reading

Merck & Co., Inc. (MRK): Select Joint Ventures, Partnerships, and Alliances

Friday, 07 September 2007

According to the Merck licensing and partnership website, "Eleven of our 20 new products launched since 1995 are the result of licensing alliances."  The site lists Merck's partners, which include small and medium-sized pharma, universities, and biotech firms, but none of their big pharma competitors.

Select Joint Ventures, Partnerships, and Alliances with Small and Midsized Pharma Continue Reading

Abbott (ABT): Select Joint Ventures, Partnerships, and Alliances

Monday, 10 September 2007

Select Joint Ventures, Partnerships, and Alliances with Big Pharma


Abbott and Millennium – In March 2001 Abbott and Millennium formed a strategic alliance for the discovery, development and commercialization of drugs and diagnostics in the area of obesity and diabetes.  This alliance also provided for non-exclusive technology transfer and the co-development of technology tools.  According to Millennium's 2001 SEC filing, the deal i Continue Reading